What is Iovance Biotherapeutics, Inc.'s investment purchases?

Iovance Biotherapeutics, Inc. (IOVA) reported investment purchases of $56M in Q1 2026.

How has Iovance Biotherapeutics, Inc.'s investment purchases changed year-over-year?

Iovance Biotherapeutics, Inc.'s investment purchases decreased by 42.8% year-over-year, from $97.92M to $56M.

What is the long-term trend for Iovance Biotherapeutics, Inc.'s investment purchases?

Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s investment purchases has grown at a -18.6% compound annual growth rate (CAGR), from $725.21M to $318.67M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Iovance Biotherapeutics, Inc. IOVA Investment Purchases

Investment Purchases at other companies

Gilead SciencesGILD

$525M—

ImmunityBio, Inc.IBRX

$139.09M+138,993%

Viridian Therapeutics, Inc.VRDN

$91.32M+28.2%

Protagonist TherapeuticsPTGX

$68.97M-67.8%

Summit TherapeuticsSMMT

$177.29M—

Vir Biotechnology, Inc.VIR

$158.37M-8.8%

Other financials

Income statement

See full

Revenue$71.4M+44.8%

Gross profit$28.9M+338%

Operating income-$81.0M+33.1%

Net income-$79.0M+32.0%

EPS (diluted)-$0.19+47.2%

Balance sheet

See full

Cash & equivalents$196.5M+14.5%

Total debt$46.8M-11.3%

Total equity$721.8M-6.0%

Total assets$925.7M-4.2%

Cash flow

See full

Operating cash flow-$72.1M+30.5%

CapEx$6.6M+6.4%

Free cash flow-$78.7M+28.4%

Valuation

See full

Market cap$1.98B+32.4%

Enterprise value$1.83B+33.2%

P/S6.9×-0.1×

Profitability

See full

Gross margin36.7%+4.1pp

Operating margin-127.2%-31.0pp

Net margin-123.9%-28.4pp

FCF margin-106.8%-27.5pp

Returns & leverage

See full

Return on equity-47.5%-3.7pp

Debt / equity0.1×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s investment purchases?: Iovance Biotherapeutics, Inc. (IOVA) reported investment purchases of $56M in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s investment purchases changed year-over-year?: Iovance Biotherapeutics, Inc.'s investment purchases decreased by 42.8% year-over-year, from $97.92M to $56M.
What is the long-term trend for Iovance Biotherapeutics, Inc.'s investment purchases?: Over 4 years (2021 to 2025), Iovance Biotherapeutics, Inc.'s investment purchases has grown at a -18.6% compound annual growth rate (CAGR), from $725.21M to $318.67M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.